These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8717383)

  • 1. Poly(lactide-co-glycolide) microencapsulation of vaccine antigens.
    Jones DH; McBride BW; Farrar GH
    J Biotechnol; 1996 Jan; 44(1-3):29-36. PubMed ID: 8717383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.
    Jones DH; McBride BW; Thornton C; O'Hagan DT; Robinson A; Farrar GH
    Infect Immun; 1996 Feb; 64(2):489-94. PubMed ID: 8550197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae.
    Jones DH; McBride BW; Jeffery H; O'Hagan DT; Robinson A; Farrar GH
    Vaccine; 1995 May; 13(7):675-81. PubMed ID: 7668037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Shahin R; Leef M; Eldridge J; Hudson M; Gilley R
    Infect Immun; 1995 Apr; 63(4):1195-200. PubMed ID: 7890372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class-specific antibody response to lymphocytosis promoting factor (LPF) and fimbriae (F) in pertussis.
    Viljanen MK; Mertsola J; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():337-40. PubMed ID: 2872122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.
    Kang ML; Jiang HL; Kang SG; Guo DD; Lee DY; Cho CS; Yoo HS
    Vaccine; 2007 Jun; 25(23):4602-10. PubMed ID: 17485148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
    Conway MA; Madrigal-Estebas L; McClean S; Brayden DJ; Mills KH
    Vaccine; 2001 Feb; 19(15-16):1940-50. PubMed ID: 11228364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and clinical use of an oral heat-inactivated whole cell pertussis vaccine.
    Baumann E; Binder BR; Falk W; Huber EG; Kurz R; Rosanelli K
    Dev Biol Stand; 1985; 61():511-6. PubMed ID: 2872129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
    Cherry JD; Chang SJ; Klein D; Lee M; Barenkamp S; Bernstein D; Edelman R; Decker MD; Greenberg DP; Keitel W; Treanor J; Ward JI
    Clin Infect Dis; 2004 Dec; 39(11):1715-8. PubMed ID: 15578376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic immune responses to pertussis infection and cellular and acellular vaccines.
    Ashworth LA; Day A; Lambert HP; Lingham S; Lissauer T; Miller E; Robinson A; Rutter DA; Thomas MG
    Ann Sclavo Collana Monogr; 1986; 3(1-2):199-211. PubMed ID: 2892507
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological responses to infection with B. pertussis.
    Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
    Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.